268
Views
5
CrossRef citations to date
0
Altmetric
Review

Barriers and Strategies: A Review of Access to Affordable Multi-Drug Resistant Tuberculosis Medication in China

, , , , ORCID Icon, & ORCID Icon show all
Pages 3679-3687 | Published online: 19 Oct 2020

Figures & data

Figure 1 Coordinated and multi-sourced financing model and comprehensive approaches to relieve the financial burden of TB patient piloted in China.

Notes: A=75% insurance listed expenditure reimbursed by the basic health insurance; B=12.5% (25%×50%) over catastrophic threshold insurance listed expenditure reimbursed by the catastrophic health insurance; C=8.75% (12,5%×70%) of the remaining insurance listed expenditure after catastrophic health insurance reimbursement covered by the medical aid program for patient in financial hardship as defined by the civil affairs department; D=3.75% (12.5%×30%) of the remaining insurance listed expenditure after catastrophic health insurance reimbursement + insurance off-list expenditure paid by patient OOP. In case that the actual proportion of OOP > safety-net threshold (due to inflated insurance off-list expenditure), the précised health poverty reduction and other safety-net programs funded by the local government offer further aids. In some areas, patient assistance program funded by the civil society or the pharmaceutical company offer supplementary aids to the MDR-TB patient in financial hardship as defined by the civil affairs department. Bold texts indicate funding from different sources. Data from Wang L and Cheng B. Theory and practice of financing and provider payment reform of tuberculosis. Beijing: People’s Health Publishing House; 2019. Chinese.Citation19
Abbreviations: OOP, out-of-pocket; MDR-TB, multidrug-resistant tuberculosis.
Figure 1 Coordinated and multi-sourced financing model and comprehensive approaches to relieve the financial burden of TB patient piloted in China.